Medtronic’s Discount Is a Weapon — If Management Has the Nerve to Use It
Medtronic trades at 21.2x earnings while sitting on 170+ active trials and a balance sheet built for deals. The...
Medtronic
Medtronic’s $100M Bet on Pulnovo Isn’t About Pulmonary Hypertension — It’s About Owning the Next Cardiovascular Platform
Medtronic's strategic investment in Pulnovo Medical's oversubscribed $100M round signals a quiet land grab in pulmonary hypertension and heart...